It's time to stop the nonsense of withholding lipid lowering therapy on account of age
- 3 February 2021
- journal article
- editorial
- Published by Elsevier BV in Atherosclerosis
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Should we treat high LDL cholesterol in ‘healthy’ elderly individuals?Atherosclerosis, 2020
- Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsThe Lancet, 2020
- Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)Journal of the American College of Cardiology, 2019
- Intensive Lipid Lowering in Elderly PatientsJAMA Cardiology, 2019
- Primary Prevention With Statins in the ElderlyJournal of Invasive Cardiology, 2018
- ESC/EAS Guidelines for the management of dyslipidaemiasAtherosclerosis, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011